Today: 10 June 2026
Browse Category

NASDAQ:ALPS 1 November 2025 - 3 November 2025

ALPS Group (NASDAQ: ALPS) Stock’s Wild Debut – Biotech Unicorn’s SPAC Merger Sparks Volatile Trading

ALPS Group (NASDAQ: ALPS) Stock’s Wild Debut – Biotech Unicorn’s SPAC Merger Sparks Volatile Trading

ALPS Group Inc. closed its Nasdaq debut at $2.56 per share on Oct. 31, 2025, after a SPAC merger, then plunged about 34% to $1.69 in pre-market trading Nov. 3. The Malaysian biotech’s public float was limited to roughly 3.5 million shares, fueling sharp volatility. Most shares remain locked up with insiders. The company raised $3.1 million in a concurrent PIPE.
3 November 2025
·
ALPS Group Inc Stock Explodes on Nasdaq Debut – Malaysian Biotech Unicorn Takes Off

ALPS Group Inc Stock Explodes on Nasdaq Debut – Malaysian Biotech Unicorn Takes Off

Alps Group Inc (ALPS) began trading on Nasdaq Oct 31, 2025, opening near $2.55 and closing at $2.56 after a SPAC merger that valued the company at $1.6 billion. First-day volume reached about 590,000 shares, with a market cap near $10–12 million. ALPS, led by CEO Dr. Tham Seng Kong, raised $3.1 million in PIPE financing. The company reported no revenue and a net loss of $2 million pre-merger.
1 November 2025
·

Stock Market Today

  • Capital Southwest Q1 Earnings Lag Specialty Finance Peers Amid Mixed Sector Results
    June 10, 2026, 4:16 PM EDT. Capital Southwest (NASDAQ:CSWC) reported Q1 revenues of $57.77 million, up 10.2% year on year but missing analyst expectations by 7%. The specialty finance sector showed mixed results, with the group beating revenue estimates by 2.1% on average but share prices declining 2.3% post-earnings. CSWC's CEO Michael Sarner highlighted $158 million in originations and a 1.1% non-accrual rate, while dividends were declared including a supplemental payment. The company raised $26 million via its Equity ATM Program and expanded leverage commitments. Despite these efforts, CSWC's shares traded flat near $23.46. Specialty finance firms face sector-specific risks but benefit from niche expertise, with varied Q1 performances across peers including top performer Encore Capital Group.

Latest articles

SpaceX IPO Orders Exceed $250 Billion, But Orbital AI’s The Watch Point

SpaceX IPO Orders Exceed $250 Billion, But Orbital AI’s The Watch Point

10 June 2026
SpaceX’s $75 billion IPO has drawn over $250 billion in investor demand, Reuters reports, as buyers scramble for shares amid a heated debate over whether Starship can make orbital AI computing commercially viable; Morningstar values the stock 53% below the IPO price, highlighting major risks as SpaceX posts a $4.3 billion Q1 loss and regulatory scrutiny intensifies ahead of pricing.
OpenAI IPO timing: Altman gives new timeline for possible trillion-dollar debut

OpenAI IPO timing: Altman gives new timeline for possible trillion-dollar debut

10 June 2026
OpenAI confirmed a confidential S-1 submission for a U.S. IPO, and CEO Sam Altman reportedly told staff he expects the company to go public “within the next year”; investors are watching closely as OpenAI prepares a tender offer at $687.69 per share and targets a potential $1 trillion valuation, with timing risks if rival AI firms list first.
Go toTop